Beauty Health (SKIN) to Release Quarterly Earnings on Thursday

Beauty Health (NASDAQ:SKIN) is expected to be announcing its Q1 2026 results after the market closes on Thursday, May 7th. Analysts expect Beauty Health to post earnings of ($0.09) per share and revenue of $66.2780 million for the quarter. Individuals can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Thursday, May 7, 2026 at 4:30 PM ET.

Beauty Health (NASDAQ:SKIN) last released its earnings results on Thursday, March 12th. The company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.01. Beauty Health had a negative return on equity of 15.40% and a negative net margin of 3.16%.The business had revenue of $82.37 million during the quarter, compared to analysts’ expectations of $78.07 million. On average, analysts expect Beauty Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Beauty Health Price Performance

Shares of SKIN opened at $0.92 on Wednesday. The firm has a market cap of $117.81 million, a PE ratio of -4.60 and a beta of 1.12. Beauty Health has a 52-week low of $0.76 and a 52-week high of $2.69. The business’s 50 day moving average price is $0.98 and its two-hundred day moving average price is $1.25. The company has a debt-to-equity ratio of 3.94, a quick ratio of 1.40 and a current ratio of 1.66.

Hedge Funds Weigh In On Beauty Health

A number of institutional investors have recently modified their holdings of SKIN. Public Employees Retirement System of Ohio acquired a new stake in Beauty Health in the 3rd quarter valued at $26,000. Atom Investors LP bought a new position in shares of Beauty Health in the fourth quarter valued at $29,000. Franklin Resources Inc. bought a new position in shares of Beauty Health in the third quarter valued at $31,000. Ieq Capital LLC acquired a new position in shares of Beauty Health during the fourth quarter valued at about $33,000. Finally, Zacks Investment Management bought a new stake in shares of Beauty Health during the third quarter worth about $35,000. 93.26% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on SKIN. TD Cowen lowered their price objective on shares of Beauty Health from $1.65 to $1.50 and set a “hold” rating for the company in a research note on Monday, March 16th. Zacks Research upgraded shares of Beauty Health from a “strong sell” rating to a “hold” rating in a report on Monday, March 16th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $1.60 price target on shares of Beauty Health in a research note on Wednesday, January 14th. Canaccord Genuity Group dropped their price objective on shares of Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a report on Friday. Finally, Benchmark reissued a “hold” rating on shares of Beauty Health in a research report on Friday, March 13th. One equities research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $2.32.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.